✦ LIBER ✦

Pharmacokinetic and Pharmacodynamic Aspects of Antibiotic Use in High-Risk Populations

✍ Scribed by Bergman, Scott J.; Speil, Cristian; Short, Michael; Koirala, Janak

Book ID: 121321983
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 288 KB
Volume: 21
Category: Article
ISSN: 0891-5520
DOI: 10.1016/j.idc.2007.07.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of antibiotics revisited in lungs

✍ Kentarchos, N.E. 📂 Article 📅 2006 🏛 Masson Editeur 🌐 French ⚖ 252 KB

Use of pharmacokinetic/ pharmacodynamic

Use of pharmacokinetic/ pharmacodynamic modelling for starting dose selection in first-in-human trials of high-risk biologics

✍ Balaji M. Agoram 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 634 KB

Prospective Use of Population Pharmacoki

Prospective Use of Population Pharmacokinetics/ Pharmacodynamics in the Development of Cisatracurium

✍ Virginia D. Schmith; Jill Fiedler-Kelly; Luann Phillips; Thaddeus H. Grasela 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 531 KB

Aspects of pharmacokinetics and pharmaco

Aspects of pharmacokinetics and pharmacodynamics of sufentanil in pediatric practice

✍ Stefan Lundeberg; James A. Roelofse 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Population pharmacokinetics and pharmaco

Population pharmacokinetics and pharmacodynamics of biapenem in paediatric patients

✍ K. Ikawa; N. Morikawa; K. Ikeda; M. Miki; S. Nishimura; M. Kobayashi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB

Psychological aspects of cancer screenin

Psychological aspects of cancer screening in high-risk populations

✍ Kash, Kathryn M. ;Dabney, Mary Kay 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

## Abstract ## Background The focus of this paper is to define who is at high risk for breast cancer and the psychological issues in breast cancer screening. Within this context, the emphasis is on secondary malignancies after treatment for childhood cancers, including age appropriate guidelines f